[go: up one dir, main page]

WO2003072767A3 - Regulation of human lipase - Google Patents

Regulation of human lipase Download PDF

Info

Publication number
WO2003072767A3
WO2003072767A3 PCT/EP2003/001940 EP0301940W WO03072767A3 WO 2003072767 A3 WO2003072767 A3 WO 2003072767A3 EP 0301940 W EP0301940 W EP 0301940W WO 03072767 A3 WO03072767 A3 WO 03072767A3
Authority
WO
WIPO (PCT)
Prior art keywords
human lipase
regulation
disorders
reagents
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2003/001940
Other languages
French (fr)
Other versions
WO2003072767A2 (en
Inventor
Jiing-Ren Liou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Priority to AU2003218668A priority Critical patent/AU2003218668A1/en
Publication of WO2003072767A2 publication Critical patent/WO2003072767A2/en
Publication of WO2003072767A3 publication Critical patent/WO2003072767A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Reagents that regulate human lipase and reagents which bind to human lipase gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, diabetes, CNS disorders, asthma, obesity, cardiovascular disorders, and urological disorders.
PCT/EP2003/001940 2002-02-27 2003-02-26 Regulation of human lipase Ceased WO2003072767A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003218668A AU2003218668A1 (en) 2002-02-27 2003-02-26 Regulation of human lipase

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US35963402P 2002-02-27 2002-02-27
US60/359,634 2002-02-27
US36310102P 2002-03-12 2002-03-12
US60/363,101 2002-03-12
US39913302P 2002-07-30 2002-07-30
US60/399,133 2002-07-30
US40336002P 2002-08-15 2002-08-15
US60/403,360 2002-08-15

Publications (2)

Publication Number Publication Date
WO2003072767A2 WO2003072767A2 (en) 2003-09-04
WO2003072767A3 true WO2003072767A3 (en) 2004-03-11

Family

ID=27767926

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/001940 Ceased WO2003072767A2 (en) 2002-02-27 2003-02-26 Regulation of human lipase

Country Status (2)

Country Link
AU (1) AU2003218668A1 (en)
WO (1) WO2003072767A2 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032885A2 (en) * 1999-11-05 2001-05-10 Millennium Pharmaceuticals, Inc. Human lipase
WO2001057188A2 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001064907A2 (en) * 2000-03-02 2001-09-07 Incyte Genomics, Inc. Lipid metabolism enzymes
WO2001098342A1 (en) * 2000-06-22 2001-12-27 Smithkline Beecham Corporation Novel compounds
WO2002002762A1 (en) * 2000-07-03 2002-01-10 Mochida Pharmaceutical Co., Ltd. Novel lipase
WO2002024898A2 (en) * 2000-09-25 2002-03-28 Millennium Pharmaceuticals, Inc. 47647, a human lipase and uses therefor
WO2002031131A1 (en) * 2000-10-11 2002-04-18 Mochida Pharmaceutical Co., Ltd. Novel pla1
WO2002063005A2 (en) * 2001-02-06 2002-08-15 Incyte Genomics, Inc. Lipid-associated molecules

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032885A2 (en) * 1999-11-05 2001-05-10 Millennium Pharmaceuticals, Inc. Human lipase
WO2001057188A2 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001064907A2 (en) * 2000-03-02 2001-09-07 Incyte Genomics, Inc. Lipid metabolism enzymes
WO2001098342A1 (en) * 2000-06-22 2001-12-27 Smithkline Beecham Corporation Novel compounds
WO2002002762A1 (en) * 2000-07-03 2002-01-10 Mochida Pharmaceutical Co., Ltd. Novel lipase
EP1298205A1 (en) * 2000-07-03 2003-04-02 Mochida Pharmaceutical Co., Ltd. Novel lipase
WO2002024898A2 (en) * 2000-09-25 2002-03-28 Millennium Pharmaceuticals, Inc. 47647, a human lipase and uses therefor
WO2002031131A1 (en) * 2000-10-11 2002-04-18 Mochida Pharmaceutical Co., Ltd. Novel pla1
EP1329501A1 (en) * 2000-10-11 2003-07-23 Mochida Pharmaceutical Co., Ltd. Novel pla1
WO2002063005A2 (en) * 2001-02-06 2002-08-15 Incyte Genomics, Inc. Lipid-associated molecules

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GILLER T ET AL: "TWO NOVEL HUMAN PANCREATIC LIPASE RELATED PROTEINS HPLRP1 AND HPLRP2 DIFFERENCES IN COLIPASE DEPENDENCE AND IN LIPASE ACTIVITY", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 267, no. 23, 1992, pages 16509 - 16516, XP002251906, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
AU2003218668A8 (en) 2003-09-09
AU2003218668A1 (en) 2003-09-09
WO2003072767A2 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
WO2002036754A3 (en) Nucleotide and polypeptide sequence of human lysosomal acid lipase
WO2002061092A3 (en) Regulation of human lysyl oxidase
WO2004031375A3 (en) Regulation of human 3’, 5’ cyclic nucleotide phosphodiesterase pde1c
WO2003072767A3 (en) Regulation of human lipase
WO2001077149A3 (en) Regulation of human cyslt2-like gpcr protein
WO2002031160A3 (en) Regulation of human phospholipase a2-like enzyme
WO2003052088A3 (en) Regulation of human sialyltransferase
WO2002032938A3 (en) Regulation of human pgc-1-like protein
WO2002031162A3 (en) Regulation of human phospholipase a2-like enzyme
WO2002055710A3 (en) Regulation of human purple acid phosphatase
WO2002031161A3 (en) Regulation of human phospholipase-like enzyme
WO2002099106A3 (en) Regulation of human secretin -type gpcr
WO2002042435A3 (en) Regulation of human tyrosine phosphatase
WO2002062974A3 (en) Regulation of human elongase hselo1-like protein
WO2003100087A3 (en) Regulation of novel human asparagine-hydroxylases
WO2002000855A3 (en) Regulation of human s-acyl fatty acid synthase thioesterase-like enzyme
WO2002031125A3 (en) Human phospholipase a2-like enzyme
WO2002062975A3 (en) Regulation of human elongase hselo1-like protein
WO2002036613A3 (en) Regulation of human patched-like protein
WO2002046403A3 (en) Regulation of human patched-like protein
WO2002020747A3 (en) Regulation of human tyrosine phosphatase-like enzyme
WO2002101043A3 (en) Regulation of human ta4 receptor
WO2003000903A3 (en) Regulation of human nek-like serine/threonine protein kinase
WO2004031234A3 (en) Regulation of human calcium-independent alpha-latrotoxin receptor
WO2002081704A3 (en) Regulation of human protein kinase-like protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP